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A B S T R A C T
Both fructose overconsumption and increased glucocorticoids secondary to chronic stress may contribute to
overall dyslipidemia. In this study we speciﬁcally assessed the eﬀects and interactions of dietary fructose and
chronic stress on lipid metabolism in the visceral adipose tissue (VAT) of male Wistar rats.
We analyzed the eﬀects of 9-week 20% high fructose diet and 4-week chronic unpredictable stress, separately
and in combination, on VAT histology, glucocorticoid prereceptor metabolism, glucocorticoid receptor sub-
cellular redistribution and expression of major metabolic genes. Blood triglycerides and fatty acid composition
were also measured to assess hepatic Δ9 desaturase activity.
The results showed that fructose diet increased blood triglycerides and Δ9 desaturase activity. On the other
hand, stress led to corticosterone elevation, glucocorticoid receptor activation and decrease in adipocyte size,
while phosphoenolpyruvate carboxykinase, adipose tissue triglyceride lipase, FAT/CD36 and sterol regulatory
element binding protein-1c (SREBP-1c) were increased, pointing to VAT lipolysis and glyceroneogenesis. The
combination of stress and fructose diet was associated with marked stimulation of fatty acid synthase and acetyl-
CoA carboxylase mRNA level and with increased 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-
phosphate dehydrogenase protein levels, suggesting a coordinated increase in hexose monophosphate shunt and
de novo lipogenesis. It however did not inﬂuence the level of peroxisome proliferator-activated receptor-gamma,
SREBP-1c and carbohydrate responsive element-binding protein.
In conclusion, our results showed that only combination of dietary fructose and stress increase glucocorticoid
prereceptor metabolism and stimulates lipogenic enzyme expression suggesting that interaction between stress
and fructose may be instrumental in promoting VAT expansion and dysfunction.
1. Introduction
Overconsumption of energy-dense food in combination with ev-
eryday stress represents a hallmark of modern lifestyle and coincides
with the rising incidence of obesity, metabolic syndrome and type 2
diabetes. It is well documented that the consumption of large amounts
of liquid fructose may induce features of metabolic syndrome, including
dyslipidemia, insulin resistance and adipose tissue dysfunction
(Basciano et al., 2005). Fructose consumption was largely increased
over past few decades mainly through utilization of high fructose corn
syrup in food industry, which expanded its use as a sweetener in soft
drinks and juice beverages (Bray et al., 2004). It is now well docu-
mented that fructose is involved in the genesis and progression of the
metabolic syndrome mainly through deregulation of signaling
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pathways in the liver and adipose tissue, which are tissues with insulin-
modulated metabolism (Miller and Adeli, 2008). Apart from the diet, it
is also known that chronic stressors cause physiological and neu-
roendocrine changes that are associated with increased food intake and
have been related to visceral obesity and insulin resistance in both
animals and humans (Kouvonen et al., 2005). It was previously shown
that this type of obesity, characterized by the accumulation of excessive
fat around the abdomen, is strongly correlated with cardiovascular and
metabolic diseases (Despres et al., 2008).
Glucocorticoids are known as stress and anti-inﬂammatory hor-
mones, but they also act as potent regulators of adipose tissue energy
metabolism (Wang, 2005). It has been suggested that systemic hy-
percortisolemia or local generation of active glucocorticoids in visceral
adipose tissue (VAT), mediated by the enzymes 11β-hydroxysteroid
dehydrogenase type 1 (11βHSD1) and hexose-6-phosphate dehy-
drogenase (H6PDH), can increase visceral adiposity and have deleter-
ious metabolic eﬀects (Walker, 2006). Despite considerable evidence
that connects 11βHSD1 overexpression in adipose tissue and develop-
ment of visceral obesity (Livingstone et al., 2000; Seckl et al., 2004),
data addressing the eﬀects of stress and fructose interaction on adipose
tissue prereceptor glucocorticoid metabolism in adult rats are still
scarce. Glucocorticoids dually aﬀect lipid storage depending on the
adipose tissue depot and nutritional and/or hormonal conditions
(Lundgren et al., 2004; Peckett et al., 2011). Although some human and
in vitro studies showed that glucocorticoids preferably induce lipolysis
in subcutaneous adipose tissue (Ryden and Arner, 2017; Stimson et al.,
2017), rodent studies revealed that glucocorticoid-induced lipolysis is
rather related to VAT (Bjorndal et al., 2011; Chusyd et al., 2016).
Furthermore, several lines of evidence support the hypothesis that VAT
lipolysis is actually the major contributor for obesity-related insulin
resistance through release of free fatty acids (FFAs) (Lebovitz and
Banerji, 2005; Nielsen et al., 2004). In addition, when insulin level rise
with feeding, glucocorticoids may act synergistically with insulin, in-
creasing the expression of numerous genes involved in lipogenesis and
fat deposition (Lee et al., 2014). Glucocorticoids are involved in direct
transcriptional regulation of lipolytic enzymes, hormone-sensitive li-
pase (Hsl) and adipose tissue triglyceride lipase (Atgl) (Campbell et al.,
2009a), through activation of glucocorticoid receptor (GR). In addition,
fatty acid translocase (FAT/CD36) was also shown to be involved in
glucocorticoid-mediated lipolysis (Lee et al., 2014; Yu et al., 2010), as
well as in fatty acid re-esteriﬁcation (Wan et al., 2013). On the other
hand, glucocorticoids can modulate expression of several prolipogenic
factors, including genes involved in lipid intake (lipoprotein lipase, Lpl),
de novo lipogenesis (DNL) (acetyl-CoA carboxylase, Acc and fatty acid
synthase, Fas) (Campbell et al., 2011; Wang et al., 2012) and glycer-
oneogenesis (phosphoenolpyruvate carboxykinase, Pepck) (Nechushtan
et al., 1987).
Apart from GR, a complex network of transcription factors regulated
by insulin is involved in the control of adipose tissue development and
lipid homeostasis. Among them, the peroxisome proliferator activated
receptor γ (PPARγ) upregulates the transcription of genes involved in
fatty acid metabolism and triglyceride (TG) storage, promoting adipo-
genesis and the fatty acid ﬂux into adipocytes (Rosen and Spiegelman,
2001; Rosen et al., 2000), while the sterol regulatory element binding
protein-1c (SREBP-1c) assists adipo/lipogenesis (Kim and Spiegelman,
1996; Tontonoz et al., 1993). Recently, carbohydrate responsive ele-
ment binding protein (ChREBP) emerged as a pivotal transcriptional
inducer of glucose usage and DNL in the adipose tissue, especially in
response to a large amount of carbohydrates (Herman et al., 2012).
Although excessive fructose consumption has been suggested to
contribute to the pathogenesis of metabolic syndrome, the contributory
role of stress in the worsening of dietary fructose lipogenic properties in
animal models is still missing. The aim of this work was to characterize
metabolic disturbances driven by combination of dietary fructose and
chronic stress on adult male Wistar rats and to investigate whether
glucocorticoid signaling in VAT is involved in their harmful metabolic
eﬀects. To that end, we analyzed the eﬀects of a 9-week 20% fructose-
enriched diet and 4-week chronic unpredictable stress, separately and
in combination, on energy intake, body mass, VAT mass and histology,
GR activity, as well as the expression of glucocorticoid-target genes
related to fatty acid release, transport and storage in the VAT of male
Wistar rats.
2. Materials and methods
2.1. Animals and treatment
Male Wistar rats (2.5 months old), bred in our laboratory, were
randomly divided into four experimental groups (n=8–9 animals per
group), housed three per cage and kept in a temperature-controlled
room (22 ± 2 °C) with a 12 h light/dark cycle (lights on at 7 a.m.)
during 9 weeks. Control group (C) had standard diet (commercial chow
and drinking water), while fructose group (F) had access to the same
food and 20% (w/v) fructose solution instead of drinking water. The
detailed composition of the diet was described previously by Velickovic
et al. (2013). Stress group (S) had standard diet like the C group and
was subjected to chronic unpredictable stress during the last 4 weeks of
the 9-week dietary treatment. The Stress + Fructose group (SF) had the
diet regime like the F group and was exposed to stress like the S group.
The stress protocol was a modiﬁed protocol of Joels et al. (2004) and
included the following daily stressors: forced swimming in cold water
for 10min, physical restraint for 30min, exposure to a cold room (4 °C)
for 50min, wet bedding for 4 h, rocking cages for 1 h and cage tilt (45°)
overnight. The time and type of daily stressors were randomly selected
at the beginning of the treatment. All experimental groups had ad li-
bitum access to food and drinking ﬂuid and daily food and ﬂuid intake
were measured during the 9 weeks. Energy intake for control and
stressed rats was calculated by summing the calories ingested as food,
while for fructose-fed rats it was calculated as sum of calories ingested
by both food and fructose solution. All animal procedures were in
compliance with the EEC Directive 2010/63/EU on the protection of
animals used for experimental and other scientiﬁc purposes, and were
approved by the Ethical Committee for the Use of Laboratory Animals
of the Institute for Biological Research “Siniša Stanković”, University of
Belgrade.
2.2. Determination of plasma TGs, FFAs, insulin and corticosterone
At the end of 9-week dietary treatment, animals were exposed to
overnight fasting and sacriﬁced by rapid decapitation with a guillotine
(Harvard Apparatus, Holliston, MA, USA). Trunk blood was rapidly
collected into EDTA containing tubes and TG concentrations in the
blood were immediately measured by MultiCare strips (Biochemical
Systems International, Arezzo, Italia).
For determination of FFAs blood plasma was prepared by low speed
centrifugation (1600 g/10min). The separated plasma was stored at
−20 °C for subsequent processing. Plasma FFAs were measured color-
imetrically by the Semi-auto Chemistry Analyzer (Rayito, 1904C) using
a Randox NEFA kit (Randox Laboratories Ltd, Crumlin, UK).
Plasma insulin concentrations were determined by RIA method,
using rat insulin standards (INEP, Belgrade, Serbia). The assay sensi-
tivity was 0.6 mIU/l and intra-assay coeﬃcient of variation (CV) was
5.24%.
Plasma corticosterone concentrations were determined by using
Corticosterone EIA kit according to manufacturer's instructions
(Immunodiagnostic Systems LTD, The Boldons, UK). Absorbance at
450 nm (reference 650 nm) was measured spectrophotometrically
(Multiskan Spectrum, Thermo Fisher Scientiﬁc, Waltham, MA, USA).
Corticosterone concentrations were determined using 4PL curve ﬁtting
method (Prism 5.0, GraphPad Software, Inc., La Jolla, CA, USA) and
given as ng/ml. The assay sensitivity was 0.17 ng/ml. Intra-assay and
inter-assay CVs were 5.9% and 8.9%, respectively.
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2.3. Determination of fatty acid proﬁle of total plasma lipids
Total plasma lipids were extracted by the method of Glaser et al.
(2010) as follows: 100 μl of plasma was combined with 1.5ml metha-
nolic HCl (3 N, containing 2 g/l 2,6-di-tert-butyl-p-cresol) and heated to
85 °C for 45min. When cooled, 1ml hexane was added and centrifuged
(657 g/10min). After phase separation, 0.5 ml of the upper hexane
phase was evaporated under nitrogen stream and stored at−20 °C until
use. Fatty acid composition of total plasma lipids was analyzed ac-
cording to protocol described by Petrovic et al. (2016). The sample was
dissolved in 10 μl of hexane and 1 μl was injected into a gas chroma-
tograph Shimadzu GC 2014 (Shimadzu Co., Tokyo, Japan) equipped
with a ﬂame ionization detector and Rtx 2330 fused silica gel capillary
column (60m×0.25mm x 0.2 μm) (Restek Co., Bellefonte, PA, USA).
The ﬂame ionization detector was set at 260 °C and the injection port at
220 °C, the oven temperature was 140 °C for 5min and heating rate
3 °C/min from 140 °C to 220 °C. Individual fatty acid methyl esters in
the samples were identiﬁed by comparing sample peak retention times
with authentic standards (Sigma Chemical Co., St Louis, MO, USA) and/
or polyunsaturated fatty acid (PUFA)-2 standard mixture (Restek Co.,
Bellefonte, PA, USA). Fatty acid proﬁles were expressed as the per-
centage areas of total fatty acids. The Δ9 desaturase activity was esti-
mated as the product-to-precursor ratio of 18:1/18:0 (Petrovic et al.,
2016).
2.4. Isolation and histological analysis of VAT
VAT (pooled depots of retroperitoneal and perirenal white adipose
tissue) (Chusyd et al., 2016) was excised immediately after decapita-
tion, washed by 0.9% NaCl, dried, weighed and frozen in liquid ni-
trogen for subsequent processing. For RNA and protein isolation, tissues
from three animals per experimental group were pooled. Additionally,
for histological analysis of VAT, samples from individual rats were ﬁxed
in 10% neutral formalin for 24 h, dehydrated in an ethanol gradient,
cleared in xylene and embedded in paraﬃn. Tissue blocks were sec-
tioned at 10 μm thickness and stained with hematoxylin and eosin.
Morphometric analysis, i.e. determination of adipocyte cell diameter
and sectional area, was carried out using Adiposoft (automated soft-
ware for the analysis of white adipose tissue cellularity in histological
sections) (Galarraga et al., 2012). Images for analysis were acquired
using a workstation comprising a microscope (Olympus, BX-51,
Olympus Corp., Tokyo, Japan) equipped with a CCD video camera
(PixeLINK, Ottawa, ON, Canada) connected to a PC monitor. The whole
system was controlled by the newCAST software package (Visiopharm
Integrator System, version 3.2.7.0, Visiopharm, Horsholm, Denmark).
Three high-resolution, randomly located images per section were ac-
quired at 10×magniﬁcation. The cell diameter and area were de-
termined in 100 adipocytes per section (three sections per animal and
six animals per group).
2.5. Preparation of subcellular fractions
For the preparation of subcellular fractions, frozen adipose tissue
was homogenized (w/v= 1:1) in ice-cold 20mM Tris-HCl (pH 7.2)
buﬀer containing 10% glycerol, 50 mM NaCl, 1 mM EDTA-Na2, 1mM
EGTA-Na2, 2mM dithiothretiol (DTT), protease inhibitors (20mM
Na2MoO4, 0.15mM spermin, 0.15mM spermidin, 0.1mM PMSF, 5 μg/
ml antipain, 5 μg/ml leupeptin, 5 μg/ml aprotinin) and phosphatase
inhibitors (20mM β-glycerophosphate, 5mM Na4P2O7x10H2O, 25mM
NaF). The homogenates were further processed to obtain cytoplasmic
and nuclear fractions, as described previously (Bursac et al., 2013).
Total protein fraction was isolated from the adipose tissue using TRIzol®
Reagent (AmBion, Life Technologies, Carlsbad, CA, USA) according to
the manufacturer's instruction. Brieﬂy, tissues were mechanically
homogenized by adding TRI Reagent Solution containing TRIzol® Re-
agent, 1mM PMSF and 2mM EDTA and centrifuged (12 000 g for
15min at 4 °C). The protein fraction (phenol ethanol supernatant) was
precipitated with acetone for 10min at room temperature and cen-
trifuged (12000 g for 10min at 4 °C). Pellets were dispersed in 0.3M
guanidine hydrochloride in 95% ethanol with 2.5% glycerol by soni-
cation on ice (3× 5 s, 1 A, 50/60 Hz), centrifuged (8000 g for 5min at
4 °C) and washed two more times in 0.3M guanidine hydrochloride in
95% ethanol with 2.5% glycerol followed by low speed centrifugation
(8000 g for 5min at 4 °C). Finally, pellets were dispersed in the lysis
buﬀer (2.5 mM Tris-HCl pH 6.8, 2% w/v sodium dodecyl sulfate (SDS),
10% glycerol, 50mM DTT) and used as total protein fractions. All
samples were stored at −70 °C until use.
2.6. RNA isolation, reverse transcription and real-time PCR
Total RNA was isolated from VAT using TRIzol® Reagent (AmBion,
Life Technologies, Carlsbad, CA, USA) according to manufacturer's in-
structions simultaneously with total protein isolation described above.
Quantitative and qualitative evaluation of the isolated RNA was per-
formed spectrophotometrically (OD 260/280 > 1.8 was considered
satisfactory) and on 2% agarose gel. Prior to cDNA synthesis, DNA
contamination was removed by DNAse I treatment (Fermentas,
Burlington, ON, Canada). Reverse transcription was performed using a
high capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, USA) according to manufacturer's instructions. The
cDNAs were stored at −70 °C until use.
TaqMan® gene expression probe sets (Applied Biosystems Assay-on-
Demand Gene Expression Products) were used for all gene expression
experiments. All probe sets used, Acc (Rn00573474_m1*), Lipe/Hsl
(Rn00563444_m1*), Pepck (Rn01529014_m1*), Atgl (PNPLA2,
Rn01479969_m1*), Lpl (Rn00561482_m1*), Cd36 (Rn02115479_g1*)
and Fas (Rn01463550_m1*), were FAM labeled. Quantitative normal-
ization of cDNA in each sample was performed using Hprt1
(Rn01527840_m1*) as endogenous control. Real-time PCR reaction was
performed using QuantStudio™ Real-Time PCR Systems (Applied
Biosystems, Foster City, CA, USA) in a total volume of 20 μl containing
1 × TaqMan Universal Master Mix with AmpErase UNG, 1 × Assay Mix
(Applied Biosystems, Foster City, CA, USA) and cDNA template (20 ng).
Thermal cycling conditions were as follows: 50 °C for 2 min, 95 °C for
10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 60 s. No
template control was used in each run. All reactions were run in tri-
plicates. Relative quantiﬁcation of gene expression was examined using
comparative 2–ΔΔct method described by Livak and Schmittgen (2001).
The results were analyzed by Quant Studio™ Design & Analysis v1.3.1
(Applied Biosystems, Foster City, CA, USA) with a conﬁdence level of
95% (p≤ 0.05).
2.7. Western blot analysis
Protein concentration in all fractions was determined by the method
of Lowry et al. (1951) using bovine serum albumin as a reference. The
samples were boiled in equal volumes of 2× Laemmli's buﬀer for 5min
and 50 μg of proteins were subjected to electrophoresis on 7.5% SDS-
polyacrylamide gel along with molecular mass references (10–170 kDa)
(Thermo Fisher Scientiﬁc, Waltham, MA, USA). After electrophoresis,
proteins were transferred onto PVDF membrane (Immobilon-P, Milli-
pore, Bedford, MA, USA) using a blot system (Transblot, Bio-Rad La-
boratories, Hercules, CA, USA). Membranes were blocked for 1 h with
2% non-fat dry milk dissolved in phosphate buﬀered saline (PBS) at
room temperature and incubated with the respective primary and sec-
ondary antibodies. GR was detected by sc-8992 antibody (1:250) (Santa
Cruz Biotechnology, Dallas, TX, USA), PPARγ by sc-9000 antibody
(1:500) (Santa Cruz Biotechnology, Dallas, TX, USA), 11βHSD1 by
ab393364 antibody (1:1000) (Abcam, Cambridge, UK), H6PDH by sc-
67394 antibody (1:1000) (Santa Cruz Biotechnology, Dallas, TX, USA),
SREBP-1c by sc-366 antibody (1:1000) (Santa Cruz Biotechnology,
Dallas, TX, USA) and ChREBP by NB400-135 (1:500) (Novus
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Biologicals, Littleton, CO, USA). For cytoplasmic fraction and total
protein, anti-β-actin AC-15 (1:10000) (Sigma-Aldrich, St. Louis, MO,
USA) was used as loading control, while anti-TBP ab63766 (Abcam,
Cambridge, UK) antibody was used as loading control for nuclear
fraction. Secondary antibodies were horseradish peroxidase (HRP)-
linked goat anti-rabbit antibody (IgG H&L) ab6721 (1:20000) (Abcam,
Cambridge, UK) or HRP-linked rabbit anti-mouse (IgG H&L) antibody
ab97046 (1:20000) (Abcam, Cambridge, UK). Immunoreactive bands
were developed by enhanced chemiluminescent substrate and exposed
to X-ray ﬁlms (Kodak, Rochester, NY, USA). Densitometry of protein
bands on X-ray ﬁlm was performed by Image J analysis PC software
(NIH, Bethesda, MD, USA). To correct for equal protein load in all
samples, membranes were incubated in stripping buﬀer, reblocked and
probed with β-actin antibody.
2.8. Statistical analysis
Physiological and biochemical data are presented as means ± SD,
while histological data and data from Western blot analysis and real-
time PCR are presented as means ± SEM. To determine the eﬀects of
the fructose and stress treatment, as well as their interaction, two-way
ANOVA followed by post hoc Tukey test was used. Statistical sig-
niﬁcance was accepted at p < 0.05.
3. Results
3.1. Physiological measurements
To reveal the eﬀects of stress and dietary fructose and their com-
bination on physiological parameters we analyzed energy intake, as
well as body and VAT mass. As shown in Table 1, both groups con-
suming fructose ingested more total kJ than the rats drinking water
(p < 0.001, F vs. C; SF vs. C), and also fructose-fed stressed rats con-
sumed more total kJ in comparison to stress alone (p < 0.001, SF vs.
S). Despite increased energy intake in fructose-fed rats, body weight
was similar in all groups, regardless of diet regime or stress exposure.
On the other hand, despite a normal energy intake, stressed rats showed
a signiﬁcantly reduced VAT mass (p < 0.01, S vs. C) and VAT/body
ratio (Table 1, p < 0.01, S vs. C) compared to control animals.
3.2. Biochemical measurements of plasma TGs, FFAs, insulin and
corticosterone
As shown in Table 2, fructose-fed rats had signiﬁcantly increased
plasma TG compared to the control animals (p < 0.001, F vs. C).
Furthermore, plasma TG were elevated in stressed rats on fructose diet
in comparison to the stressed animals (p < 0.05, SF vs. S), and de-
creased in comparison to fructose-fed animals (p < 0.05, SF vs. F).
An increase of plasma FFAs level was observed in fructose-fed
stressed rats in comparison to both control and stressed animals
(p < 0.05, SF vs. C; SF vs. S).
Dietary fructose signiﬁcantly increased plasma insulin levels in both
fructose-fed groups compared to the control group (Table 2, p < 0.05,
F vs. C; SF vs. C). Furthermore, a signiﬁcant increase of plasma insulin
level in stressed animals on fructose diet in comparison to stressed
animals on standard diet was also observed (Table 2, p < 0.05, SF vs.
S).
A signiﬁcant increase of plasma corticosterone level was detected in
stressed animals on standard diet in comparison to the control animals
(Table 2, p < 0.001, S vs. C), while corticosterone level was sig-
niﬁcantly decreased in fructose-fed stressed rats in comparison to the
stressed animals (Table 2, p < 0.01, SF vs. S).
3.3. Fatty acid alterations and Δ9 desaturase activity
Table 3 shows that dietary sugar induced signiﬁcant changes in Δ9
desaturase activity, as estimated from the product-to-precursor ratio of
18:1/18:0. A signiﬁcant decrease of stearic and concomitant increase of
oleic acid was observed in all fructose-fed animals in comparison to the
control and stressed rats (p < 0.01, p < 0.001, F vs. C; p < 0.001, SF
vs. C and SF vs. S). A signiﬁcant increase of Δ9 desaturase activity was
detected in all fructose-fed animals in comparison to the control and
stressed ones (p < 0.001, F vs. C; SF vs. C and SF vs. S).
3.4. Histological and morphometrical analysis of VAT
As shown in Fig. 1, histological analysis of VAT revealed that both
adipocyte cell diameter and area were signiﬁcantly decreased only in
stressed rats as compared to the control animals (Fig. 1a and b,
p < 0.001, S vs. C).
3.5. Glucocorticoid prereceptor metabolism and signaling
To investigate the eﬀects of fructose overconsumption and/or
chronic exposure to unpredictable stress on the glucocorticoid pre-
receptor metabolism, protein levels of 11βHSD1 and H6PDH enzymes
were analyzed in the total protein extract of VAT. As shown in Fig. 2a, a
signiﬁcant increase of 11βHSD1 and H6PDH protein levels was ob-
served only in stressed animals on fructose diet in respect to all other
experimental groups (p < 0.01 for SF vs. C and SF vs. F; p < 0.05, SF
vs. S).
In order to analyze eﬀects of fructose diet and/or stress on the GR
expression and function in the VAT, we followed the redistribution of
GR protein from the cytoplasm to the nuclei. The results showed a
signiﬁcant increase of GR protein level in the VAT nuclei of stressed rats
in comparison to the control group (Fig. 2b, p < 0.05, S vs. C).
Table 1
Physiological measurements: energy intake, body and VAT mass in control rats, fructose-fed rats, rats exposed to chronic unpredictable stress, and fructose-fed
stressed rats.
Control Fructose Stress Stress + Fructose Two-way ANOVA
Fructose Stress Interaction
Energy intake (kJ/day/animal) 182.0 ± 18.0 262.0 ± 51.9b 175.7 ± 23.2 248.7 ± 47.0b,c p < 0.001 NS NS
Body mass (g) 369 ± 18 330 ± 38 338 ± 39 338 ± 43 NS NS NS
Mass of VAT (g) 7.67 ± 1.67 7.80 ± 2.40 4.43 ± 1.39a 6.11 ± 1.86 NS p < 0.001 NS
VAT/body ratio (× 1000) 20.80 ± 4.53 21.54 ± 5.11 13.00 ± 3.09a 18.55 ± 6.55 p < 0.05 p < 0.001 NS
The data are presented as means ± SD (n=8–9 animals per group). A value of p < 0.05 was considered statistically signiﬁcant. Signiﬁcant between-groups
diﬀerences obtained from two-way ANOVA followed by post hoc Tukey test are given as follows:
NS: not signiﬁcant.
a p < 0.01.
b p < 0.001, treated animals vs. C.
c p < 0.001, SF vs. S.
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3.6. Transcriptional regulators involved in VAT lipid metabolism
To determine whether fructose diet and stress aﬀect activation of
adipo/lipogenic transcriptional regulators, the protein levels of PPARγ,
SREBP-1c and ChREBP were determined. The total protein level of
PPARγ was not aﬀected by any of the treatments (Fig. 3, left). Nuclear
SREBP-1c protein level was signiﬁcantly increased in stressed rats on
standard diet compared to the controls, and signiﬁcantly decreased
after the combined treatment in comparison to stress alone (Fig. 3,
middle, p < 0.01, S vs. C and SF vs. S). However, important regulator
of adipocyte lipogenesis, ChREBP was not aﬀected by any of the
treatments (Fig. 3, right).
3.7. GR-regulated genes involved in VAT lipid metabolism
The expression of GR target genes involved in lipid metabolism was
Table 2
Biochemical measurements in plasma: TGs, FFAs, insulin and corticosterone in control rats, fructose-fed rats, rats exposed to chronic unpredictable stress, and
fructose-fed stressed rats.
Control Fructose Stress Stress + Fructose Two-way ANOVA
Fructose Stress Interaction
TG (mmol/L) 1.13 ± 0.21 1.87 ± 0.40b 1.03 ± 0.18 1.48 ± 0.38c,d p < 0.001 p < 0.05 NS
FFAs (mmol/L) 0.77 ± 0.22 0.90 ± 0.32 0.80 ± 0.17 1.15 ± 0.27a,d p < 0.01 NS NS
Insulin (mIU/L) 10.07 ± 6.41 19.44 ± 8.48a 10.62 ± 6.22 20.84 ± 10.74a,d p < 0.001 NS NS
Corticosterone (ng/ml) 135.78 ± 45.26 118.91 ± 39.64 570.16 ± 190.05b 205.34 ± 68.45e p < 0.001 p < 0.001 p < 0.001
The data are presented as means ± SD (n=8–9 animals per group). A value of p < 0.05 is considered statistically signiﬁcant. Signiﬁcant between group diﬀerences
obtained from two-way ANOVA followed by post hoc Tukey test are given as follows:
NS: not signiﬁcant.
a p < 0.05.
b p < 0.001, treated animals vs. C.
c p < 0.05, SF vs. F.
d p < 0.05.
e p < 0.01, SF vs. S.
Table 3
Fatty acid alterations in total plasma lipids and estimated plasma Δ9 desaturase activities in control rats, fructose-fed rats, rats exposed to chronic unpredictable
stress, and fructose-fed stressed rats.
Fatty acid (%) Control Fructose Stress Fructose + Stress Two-way ANOVA
Fructose Stress Interaction
Stearic acid (18:0) 13.94 ± 0.77 11.81 ± 1.53a 14.65 ± 0.91 11.17 ± 1.05b,c p < 0.001 NS NS
Oleic acid (18:1n-9) 8.28 ± 0.76 13.60 ± 3.29b 7.71 ± 0.68 12.50 ± 1.59b,c p < 0.001 NS NS
Δ9 desaturase (18:1n-9/18:0) 0.60 ± 0.08 1.18 ± 0.40b 0.53 ± 0.07 1.14 ± 0.27b,c p < 0.001 NS NS
The data are presented as means ± SD (n= 8 animals per group). A value of p < 0.05 is considered statistically signiﬁcant. FAs concentrations are expressed in %
of totally detected FA. Signiﬁcant between group diﬀerences obtained from two-way ANOVA followed by post hoc Tukey test are given as follows:
NS: not signiﬁcant.
a p < 0.01.
b p < 0.001, treated animals vs. C.
c p < 0.001, SF vs. S.
Fig. 1. Histological and morphometric analysis of
VAT. Morphometric analysis of adipocyte cell dia-
meter (a) and area (b) and representative micro-
graphs of hematoxylin-eosin-stained sections of VAT
of control (C), fructose-fed (F), stressed (S) and
fructose-fed stressed (SF) rats (magniﬁcation× 10,
bar= 100 μm) (c). Data are presented as
mean ± SEM (100 adipocytes per section, three
sections per animal and six animals per group). A
value of p < 0.05 was considered statistically sig-
niﬁcant. Statistical analysis by two-way ANOVA
showed signiﬁcant eﬀect of stress on the adipocyte
cell diameter and area (p < 0.001). Signiﬁcant be-
tween-group diﬀerences from post hoc Tukey test are
given as follows:
***p < 0.001; treated animals vs. C.
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examined by real-time PCR (Fig. 4). As shown in Fig. 4, we found a
signiﬁcant increase of Atgl, Pepck and Cd36mRNA levels in stressed rats
in comparison to the control ones (p < 0.01 for Atgl mRNA; p < 0.05
for Cd36 and Pepck mRNA, S vs. C), as well as a signiﬁcant increase of
Atgl, Fas and Acc mRNA levels in fructose-fed stressed rats in compar-
ison to the controls (p < 0.05 for Atgl, Fas and Acc mRNA, SF vs. C). In
addition, in stressed animals on fructose diet, we observed a signiﬁcant
increase of mRNA levels for Fas and Acc in comparison to fructose-fed
(p < 0.05, SF vs. F) and stressed animals (p < 0.01 for Fas mRNA;
p < 0.05 for Acc mRNA, SF vs. S).
4. Discussion
Glucocorticoid hormones mediate the metabolic eﬀects of both
dietary carbohydrates and stress, and play an important role in adipo-
genesis and adipocyte function (Lee et al., 2014). It was previously
shown that both fructose consumption (Bray et al., 2004; Dekker et al.,
2010) and chronic stress (Dallman et al., 2003) are associated with
Fig. 2. Prereceptor glucocorticoid metabolism and GR protein level in the VAT. Representative Western blots and relative quantiﬁcation of 11βHSD1 and
H6PDH protein level in the total protein extract (a) and GR protein level in cytoplasm and nuclei (b) in the VAT of control (C), fructose-fed (F), stressed (S) and
fructose-fed stressed (SF) rats. Immunoreactivities of the 11βHSD1, H6PDH and GR are normalized to β-actin or TBP as loading controls and are expressed as
mean ± SEM (n=9 animals per group). A value of p < 0.05 was considered statistically signiﬁcant. Two-way ANOVA showed that 11βHSD1 protein level was
signiﬁcantly aﬀected by fructose (p < 0.05), stress (p < 0.01), and their interaction (p < 0.05). For the H6PDH protein level the eﬀect of fructose (p < 0.05),
stress (p < 0.01) and their interaction (p < 0.05) was observed. ANOVA also revealed that stress had the eﬀect on nuclear GR level (p < 0.01). Signiﬁcant
between-group diﬀerences from post hoc Tukey test are given as follows:
*p < 0.05; **p < 0.01; treated animals vs. C
##p < 0.01; SF vs. F
†p < 0.05; SF vs. S.
Fig. 3. Transcriptional regulators involved in VAT lipid metabolism. Representative Western blots and relative quantiﬁcation of PPARγ, nuclear SREBP-1c and
nuclear ChREBP in the VAT of control (C), fructose-fed (F), stressed (S) and fructose-fed stressed (SF) rats. Immunoreactivities of the proteins are normalized to β-
actin or TBP as loading controls and are expressed as mean ± SEM (n=9 animals per group). A value of p < 0.05 was considered statistically signiﬁcant. ANOVA
showed signiﬁcant eﬀect of fructose (p < 0.05), as well as the interaction between fructose and stress on nuclear SREBP-1c level (p < 0.05). Between-group
diﬀerences from post hoc Tukey test are given as follows:
**p < 0.01; treated animals vs. C
††p < 0.01; SF vs. S.
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obesity and related metabolic disorders, but how these two factors can
interact to aﬀect total body energy homeostasis and adipose tissue
metabolism is still largely unknown. Thus, the aim of the present study
was to investigate whether fructose consumption in combination with
chronic stress leads to an aggravation of metabolic function through
changes in VAT glucocorticoid signaling. The concentration of fructose
solution was chosen to resemble the consumption of fructose-sweetened
beverages in human population (Ventura et al., 2011), while chronic
unpredictable stress protocol consisted of psychological and physical
stressors reﬂecting their variability in modern human life (Joels et al.,
2004). The results showed typical metabolic eﬀects of fructose con-
sumption, such as dyslipidemia, and typical eﬀects of stress, such as
elevated plasma corticosterone level and decreased VAT mass in
stressed animals. However, only when stress was applied in combina-
tion with fructose diet, a disturbed adipose tissue lipid metabolism
accompanied by increased plasma FFAs was observed, which was not
mediated by insulin-dependent lipogenic transcriptional factors, but
rather by enhanced glucocorticoid prereceptor metabolism.
All rats on fructose diet had elevated energy intake, but without
change of total body mass (Table 1), which is in accordance with pre-
viously published data (Bursac et al., 2013, 2014). It is well docu-
mented that fructose diet induces dyslipidemia in humans (Tappy and
Le, 2010), while animal studies, including ours, indicated that it can
lead to insulin resistance, dyslipidemia and high blood pressure (Bursac
et al., 2013, 2014; Jurgens et al., 2005). The results from the present
study conﬁrmed hypertriglyceridemia and hyperinsulinemia as meta-
bolic hallmarks of fructose-enriched diet (Table 2). Furthermore, fruc-
tose diet aﬀected stearic and oleic fatty acid levels in the similar
manner in both fructose-fed groups, regardless of stress. Also, the ac-
tivity of Δ9 desaturase was increased in fructose-fed rats, probably
leading to increased levels of oleic acid (Table 3). It was previously
shown that increased activity of Δ9 desaturase is the main factor closely
associated with cardiometabolic risk and hypertriglyceridemia
(Warensjo et al., 2009). Finally, while fructose diet alters plasma fatty
acids in the direction of metabolic derangements, stress does not ne-
gatively contribute to the metabolic alteration.
As already mentioned, glucocorticoids can modulate both lipolysis
and lipogenesis in the adipose tissue, which may be determined by the
insulin level and/or examined adipose tissue depot (Lee et al., 2014;
Stimson et al., 2017). In our study fructose feeding alone did not aﬀect
plasma corticosterone level (Table 2), which is consistent with other
studies showing that metabolic disturbances caused by fructose are not
necessarily followed by changes in the plasma glucocorticoid levels
(Bursac et al., 2013, 2014; London and Castonguay, 2011). As expected,
plasma corticosterone level was signiﬁcantly elevated in stressed
animals on standard diet (Table 2). This was accompanied by a decrease
in VAT mass and its relative ratio to total body mass (Table 1), which
could result from GR activation (Fig. 2) and a consequent GR-mediated
induction of lipolytic pathways through increased expression of Atgl,
although Hsl mRNA level was unchanged (Fig. 4) (Shen et al., 2017).
Accordingly, in vitro study by Langin (2006) suggested that Hsl is the
major lipase for catecholamine-stimulated lipolysis, whereas Atgl
mediates triglyceride hydrolysis regulated by glucocorticoids (Villena
et al., 2004). As already mentioned, it was previously shown that glu-
cocorticoids induce lipolysis in rodent VAT (Bjorndal et al., 2011). In
line with this, histological analysis of rat VAT from our study revealed
the presence of signiﬁcantly smaller adipocytes in normal-fed stressed
animals as a presumable consequence of glucocorticoid-induced lipo-
lysis (Campbell et al., 2009a,b) (Fig. 1). Interestingly, decreased visc-
eral adiposity and elevated Atgl mRNA level have not been associated
with increased plasma FFAs in these animals (Table 2). The possible
explanation could be found in FFA re-esteriﬁcation in other tissues,
possibly liver and skeletal muscle (Reshef et al., 2003), but also in the
adipose tissue itself (Franckhauser et al., 2002). Our results point at
involvement of adipose tissue, since adipose Pepck and Cd36 mRNA
levels were increased in stressed rats (Fig. 4) and recent ﬁndings
showed that Cd36 can modulate FFA re-esteriﬁcation through regula-
tion of Pepck expression (Zhou et al., 2015).
However, the main resultant of fructose consumption combined
with stress on adipose tissue lipid metabolism were elevated plasma
FFAs, which could partially be the result of unchanged Cd36 expression
in the VAT of these animals implying that their Atgl-induced release was
not supported by the adequate uptake (Table 2 and Fig. 4) (Goldberg
et al., 2009). Also, it could be proposed that under the conditions of
fructose overload, FFA-dependent tissues such as skeletal muscles could
rather be using fructose as fuel, leaving the stress-released FFAs in the
circulation. Indeed, Laughlin (2014) have previously showed that ske-
letal muscle can directly metabolize fructose when both its plasma level
and energy demands are high, as in stressed animals on fructose diet.
Tracer studies in humans suggested that fructose can decrease fatty acid
oxidation in muscle, which could also be a contributory factor for in-
creased FFAs in the circulation (Sun and Empie, 2012). Interestingly,
although in combined treatment stressful stimuli were present, it seems
that fructose diet was able to cancel stress-induced rise of corticos-
terone at the end of treatment. Similar results were previously reported
by other authors, where stressed rats subjected to hypercaloric cafeteria
diet were hyporesponsive to stress due to reduced central reactivity
(Macedo et al., 2012), while others postulated that the increased intake
of palatable food under stress could be associated with reward-based
eating, as a mean to reduce the stress response (Adam and Epel, 2007).
Fig. 4. mRNA levels of genes involved in VAT
lipid metabolism. The levels of Atgl, Hsl, Pepck, Lpl,
Cd36, Fas and Acc mRNAs normalized to Hprt1
mRNA were determined by TaqMan real-time PCR in
the VAT from control (C), fructose-fed (F), stressed
(S) and fructose-fed stressed (SF) rats. Data are pre-
sented as mean ± SEM (n=9 animals per group) of
the triplicate analysis of RNA samples. A value of
p < 0.05 was considered statistically signiﬁcant.
The eﬀect of fructose was detected by two-way
ANOVA for Fas (p < 0.05) and Lpl (p < 0.01),
while stress aﬀected Cd36 (p < 0.001), Pepck
(p < 0.05) and Atgl (p < 0.001) mRNA levels.
Interaction between fructose and stress aﬀected Fas
(p < 0.01), Acc (p < 0.05) and Hsl (p < 0.05)
mRNA levels as detected by two-way ANOVA.
Signiﬁcant between-group diﬀerences from post hoc
Tukey test are given as follows:
*p < 0.05; **p < 0.01; treated animals vs. C
#p < 0.05; SF vs. F
†p < 0.05; ††p < 0.01; SF vs. S.
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As reviewed by Ulrich-Lai (2016), stress promotes consumption of
sugar, since both hedonic and metabolic eﬀects of sucrose contribute to
its relief through glucocorticoid action in adipose tissue and through
modulated plasticity in brain reward regions. In addition, when high fat
diet was combined with chronic stress model utilized to induce gluco-
corticoids elevation, the results were contradictory to the eﬀects of
glucocorticoids injected exogenously. The chronic stress actually im-
proved the fat diet-induced adiposity and glucose intolerance
(Balsevich et al., 2014; Bruder-Nascimento et al., 2013), which could be
clinically relevant, since it implies that exogenous therapy with glu-
cocorticoids represents a higher risk of further metabolic complications
if combined with hypercaloric diet.
However, endogenous glucocorticoids availability and action de-
pend not only on their circulating level but also on intracellular re-
generation of their active forms, mediated by the enzymes 11βHSD1
and H6PDH (Bujalska et al., 2005; Rose et al., 2010). Our results
showed that only the combination of fructose diet and chronic stress
signiﬁcantly increased both enzymes involved in the prereceptor me-
tabolism (Fig. 2), which was also conﬁrmed by signiﬁcant interaction of
factors found by two-way ANOVA analysis. Interestingly, this increase
in 11βHSD1 and H6PDH was associated with an important parameter of
dyslipidemia, increased plasma FFA level in fructose-fed stressed ani-
mals (Table 2). This result is consistent with the ﬁnding that mice
overexpressing 11βHSD1 in adipose tissue exhibit a threefold increase
in plasma FFA in the portal vein and a speciﬁc fat accumulation in the
VAT (Masuzaki et al., 2001).
Apart from elevated plasma FFAs in fructose-fed stressed rats, sig-
niﬁcant hyperinsulinemia was also present, while plasma TG showed a
trend of increase (p=0.08, SF vs. C). As already mentioned, in the
setting of hyperinsulinemia, glucocorticoids can simultaneously in-
crease pathways of both TG synthesis and breakdown (Lee et al., 2014).
Indeed, expression of genes involved in both DNL (Acc and Fas) and TG
hydrolysis (Atgl) was concomitantly increased in response to combined
treatment in the present study (Fig. 4), while the net eﬀect of these
changes were normal-sized adipocytes. It seems logical to assume that
Acc and Fas would be elevated in the VAT through insulin-regulated
lipogenic transcriptional factors, such as PPARγ, SREBP-1c and
ChREBP, especially after high-fructose diet (Herman et al., 2012;
Janevski et al., 2012; Muhlhausler and Smith, 2009). However, this was
not the case in the present study, since both PPARγ and ChREBP were
unchanged in all experimental groups, while SREBP-1c was increased
only by stress in normal-fed rats (Fig. 3). These ﬁndings imply that the
observed changes of concomitantly increased Fas, Acc and Atgl could
rather be related to the changes in glucocorticoid prereceptor meta-
bolism in the VAT. In support of this proposal is the study demon-
strating association of elevated 11βHSD1 protein level with sig-
niﬁcantly increased Fas expression in the intraperitoneal white adipose
tissue of male rats (Veyrat-Durebex et al., 2012).
In conclusion, our results showed that only the combination of
dietary fructose and chronic stress, as hallmarks of modern lifestyle,
exerts harmful eﬀects on lipid homeostasis, as judged by the increased
circulatory FFAs and stimulated lipogenic enzyme expression in the
VAT. These eﬀects are most likely conducted through the enhanced
glucocorticoid prereceptor metabolism, implying the inevitable in-
volvement of glucocorticoids in the metabolic diseases of modern
mankind. The results from this study could help ﬁghting the ongoing
obesity epidemic through nonpharmacological approach, such as life-
style intervention, with the special emphasis on stress management and
healthy well-balanced diet combined with physical activity.
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